IRIDEX Corporation
IRIDEX Corporation (IRIX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IRIX · as of Jun 9, 2026
Key Statistics
Explore IRIDEX Corporation Data
irix stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The IRIX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $2.75, representing +147.75% upside from the current price of $1.11.
Competitors & Peers
irix competitorsIRIX
ADGM
ALUR
ASBP
COCH
HOTHStock Performance
Full HistoryAbout IRIDEX Corporation
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools …
what is iridex corporation · irix stock overview · iridex corporation company profile · who is iridex corporation ceo · irix NASDAQ · iridex corporation headquarters · iridex corporation business segments
About Stock Overview & Key Data
IRIDEX Corporation (IRIX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 16, 1996. As of the latest trading session, IRIX stock price is $1.11, with a market capitalization of $19.3M. The stock has returned +12.51% over the past 12 months and -2.63% year-to-date.
According to 4 Wall Street analysts, the consensus rating for IRIDEX Corporation stock is Buy, with an average 12-month price target of $2.75. In fiscal year 2026, IRIDEX Corporation reported revenue of $52.7M and net income of -$4.4M. For detailed data — including IRIDEX Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IRIDEX Corporation (IRIX) stock price is $1.11. The stock is traded on NASDAQ under the ticker symbol IRIX. The 52-week range is $0.87 – $1.65.